SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Translational research hinges on the ability to make observations in model systems and to implement those findings into clinical applications, such as the development of diagnostic tools or targeted therapeutics. Tumor cell lines are commonly used to model carcinogenesis. The same tumor cell line can be simultaneously studied in multiple research laboratories throughout the world, theoretically generating results that are directly comparable. One important assumption in this paradigm is that researchers are working with the same cells. However, recent work using high throughput genomic analyses questions the accuracy of this assumption. Observations by our group and others suggest that experiments reported in the scientific literature may contain pre-analytic errors due to inaccurate identities of the cell lines employed. To address this problem, we developed a simple approach that enables an accurate determination of cell line identity by genotyping 34 single nucleotide polymorphisms (SNPs). Here, we describe the empirical development of a SNP panel identification assay (SPIA) compatible with routine use in the laboratory setting to ensure the identity of tumor cell lines and human tumor samples throughout the course of long term research use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548 · cited 2×
“The initial dataset included genotype data of 155 cell lines derived from different organs including: breast (50), colorectal (12), endometrial (4), glioma (11), leukemia (6), lung (27), melanoma (12), ovarian (6), pancreas (3), prostate (4), and renal (18) cell lines.”
Self-citationShort tandem repeat profiling provides an international reference standard for human cell lines
Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478
Liscovitch, M., & Ravid, D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.01.013 · Cited by 152
Cancer cell line identification by short tandem repeat profiling: power and limitations
Parson, W., Kirchebner, R., Mühlmann, R., Renner, K., Kofler, A., Schmidt, S., & Kofler, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3062fje · Cited by 129 · cited 2×
“Occasionally researchers adopt techniques to control for this problem, such as short tandem repeats (STR) DNA fingerprinting (8).”
Widely used prostate carcinoma cell lines share common origins
van Bokhoven, A., Varella‐Garcia, M., Korch, C., Hessels, D., & Miller, G. J. (2001) · The Prostate · doi:10.1002/pros.1045 · Cited by 90 · cited 1×
“Recent reports of inadvertent crosscontamination or labeling mistakes can stay hidden from researchers for years (2, 28 ).”
Cited by
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Beltran, H., Prandi, D., Mosquera, J. M., Benelli, M., Puca, L., Cyrta, J., Marotz, C., Giannopoulou, E., Chakravarthi, B. V. S. K., Varambally, S., et al. (2016) · Nature Medicine · doi:10.1038/nm.4045 · Cited by 1,685
Self-citationPersonalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Pauli, C., Hopkins, B. D., Prandi, D., Shaw, R., Fedrizzi, T., Sboner, A., Sailer, V., Augello, M., Puca, L., Rosati, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1154 · Cited by 937
Self-citationGenomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Brastianos, P. K., Horowitz, P. M., Santagata, S., Jones, R. T., McKenna, A., Getz, G., Ligon, K. L., Palescandolo, E., Van Hummelen, P., Ducar, M. D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2526 · Cited by 651
Self-citationExome sequencing identifies BRAF mutations in papillary craniopharyngiomas
Brastianos, P. K., Taylor-Weiner, A., Manley, P. E., Jones, R. T., Dias-Santagata, D., Thorner, A. R., Lawrence, M. S., Rodriguez, F. J., Bernardo, L. A., Schubert, L., et al. (2014) · Nature Genetics · doi:10.1038/ng.2868 · Cited by 521
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520
LaFramboise, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp552 · Cited by 467
Patient derived organoids to model rare prostate cancer phenotypes
Puca, L., Bareja, R., Prandi, D., Shaw, R., Benelli, M., Karthaus, W. R., Hess, J., Sigouros, M., Donoghue, A., Kossai, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04495-z · Cited by 361
Self-citationClonal evolution of chemotherapy-resistant urothelial carcinoma
Faltas, B. M., Prandi, D., Tagawa, S. T., Molina, A. M., Nanus, D. M., Sternberg, C., Rosenberg, J., Mosquera, J. M., Robinson, B., Elemento, O., et al. (2016) · Nature Genetics · doi:10.1038/ng.3692 · Cited by 294
Self-citationShih, D. J. H., Nayyar, N., Bihun, I., Dagogo-Jack, I., Gill, C. M., Aquilanti, E., Bertalan, M., Kaplan, A., D’Andrea, M. R., Chukwueke, U., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0592-7 · Cited by 289
Increased activation of p38 MAPK in COPD
Renda, T., Baraldo, S., Pelaia, G., Bazzan, E., Turato, G., Papi, A., Maestrelli, P., Maselli, R., Vatrella, A., Fabbri, L. M., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00036707 · Cited by 257
High‐throughput SNP‐based authentication of human cell lines
Castro, F., Dirks, W. G., Fähnrich, S., Hotz‐Wagenblatt, A., Pawlita, M., & Schmitt, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.27675 · Cited by 183
Romano, P., Manniello, A., Aresu, O., Armento, M., Cesaro, M., & Parodi, B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn730 · Cited by 147
Reproducibility: changing the policies and culture of cell line authentication
Freedman, L. P., Gibson, M. C., Ethier, S. P., Soule, H. R., Neve, R. M., & Reid, Y. A. (2015) · Nature Methods · doi:10.1038/nmeth.3403 · Cited by 136
Didion, J. P., Buus, R. J., Naghashfar, Z., Threadgill, D. W., Morse, H. C., & de Villena, F. P.-M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-847 · Cited by 63
Human Biosample Authentication Using the High-Throughput, Cost-Effective SNPtraceTM System
Liang-Chu, M. M. Y., Yu, M., Haverty, P. M., Koeman, J., Ziegle, J., Lee, M., Bourgon, R., & Neve, R. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116218 · Cited by 62
Characterization and authentication of cancer cell lines: an overview
Reid, Y. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-080-5_4 · Cited by 34
CeL-ID: cell line identification using RNA-seq data
Mohammad, T. A., Tsai, Y. S., Ameer, S., Chen, H.-I. H., Chiu, Y.-C., & Chen, Y. (2019) · BMC Genomics · doi:10.1186/s12864-018-5371-9 · Cited by 19
Metadata
- Authors
- Demichelis, F., Greulich, H., Macoska, J. A., Beroukhim, R., Sellers, W. R., Garraway, L., & Rubin, M. A.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02-27
- Volume
- 36
- Issue
- 7
- Pages
- 2446-2456
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2012951405
- Cited by
- 76
- References
- 6
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.